Clinical Medicine • Calcium & Bone Physiology

Pycnodysostosis Explained: CTSK Mutation, Cathepsin K Deficiency, Osteosclerosis, Acroosteolysis and Fractures

CTSK-related failure of organic bone-matrix degradation produces dense but fragile bone with a distinctive pattern of acroosteolysis, short stature and craniofacial/dental abnormalities.

Dr. Seneth Gajasinghe, MBBS, MD Updated September 12, 2026 35 min read

Pycnodysostosis has a specific place among dense-bone disorders

Osteopetrosis explains broad osteoclast-resorption failure. Pycnodysostosis explains a more specific defect in cathepsin K–mediated degradation of organic bone matrix, producing a distinctive phenotype of osteosclerosis with acroosteolysis, short stature and craniofacial/dental abnormalities.

CTSK variants → cathepsin K ↓ → organic matrix degradation ↓ → osteosclerosis with fragility.

Pycnodysostosis showing CTSK-related cathepsin K deficiency, dense but fragile bones, fractures and distal phalangeal acroosteolysis.
Pycnodysostosis showing CTSK-related cathepsin K deficiency, dense but fragile bones, fractures and distal phalangeal acroosteolysis.

What Is Pycnodysostosis?

Central Teaching Concept

The entire article should revolve around:

DENSE BONE DOES NOT NECESSARILY MEAN STRONG BONE

Central mechanism:

BIALLELIC CTSK PATHOGENIC VARIANTS CATHEPSIN K ACTIVITY ↓ OSTEOCLAST DEGRADATION OF ORGANIC BONE MATRIX ↓ BONE RESORPTION / REMODELING IMPAIRED OSTEOSCLEROSIS

but simultaneously:

ABNORMAL BONE QUALITY FRAGILITY + FRACTURES

The characteristic phenotype adds:

ACROOSTEOLYSIS SHORT STATURE CRANIOFACIAL / DENTAL ABNORMALITIES

GeneReviews describes the core phenotype as short-limbed short stature, characteristic facial appearance, osteosclerosis with fragility, terminal-phalanx acroosteolysis, delayed cranial-suture closure and clavicular dysplasia. (NCBI)

Opening — Use This Content

A child has:

  • short stature;
  • recurrent fractures;
  • dense bones on radiographs.

At first, this sounds like:

OSTEOPETROSIS

But hand radiographs reveal another striking finding:

LOSS OF THE TERMINAL PHALANGES

or:

ACROOSTEOLYSIS

The child also has:

  • a persistently open anterior fontanelle;
  • frontal bossing;
  • a small jaw;
  • delayed tooth eruption.

This combination should immediately suggest:

PYCNODYSOSTOSIS

The disease results from pathogenic variants affecting:

CTSK

which encodes:

CATHEPSIN K

Cathepsin K is a major osteoclast protease required for degradation of the organic bone matrix.

Therefore pycnodysostosis teaches an important principle:

AN OSTEOCLAST MAY BE PRESENT — YET STILL FAIL TO RESORB BONE NORMALLY

What Is Pycnodysostosis?

Pycnodysostosis is a rare inherited skeletal dysplasia caused by:

BIALLELIC PATHOGENIC VARIANTS IN CTSK

It is characterized by:

  • generalized osteosclerosis;
  • increased bone fragility;
  • recurrent fractures;
  • short-limbed short stature;
  • acroosteolysis;
  • delayed closure of cranial sutures/fontanelle;
  • characteristic craniofacial morphology;
  • dental abnormalities;
  • clavicular abnormalities.

Inheritance is:

AUTOSOMAL RECESSIVE

The condition belongs to the group of osteopetrosis and related osteoclast disorders in the 2023 Nosology of Genetic Skeletal Disorders. (NCBI)

Terminology

Pycnodysostosis may also be spelled:

PYKNODYSOSTOSIS

GeneReviews uses both terms and identifies the disorder as:

CTSK-RELATED PYKNODYSOSTOSIS

The historical term:

TOULOUSE-LAUTREC SYNDROME

is sometimes used because the artist Henri de Toulouse-Lautrec has retrospectively been considered likely to have had the disorder.

Avoid using Maroteaux-Lamy syndrome as the main synonym because that term is much more commonly used for the unrelated lysosomal-storage disorder mucopolysaccharidosis VI. (NCBI)

CTSK and Cathepsin K

Cathepsin K

Cathepsin K is a:

LYSOSOMAL CYSTEINE PROTEASE

highly expressed in osteoclasts.

It functions particularly well in the acidic environment of the osteoclast resorption compartment.

Important substrates include:

  • type I collagen;
  • type II collagen;
  • osteopontin;
  • osteonectin.

Its major skeletal role is degradation of:

ORGANIC BONE MATRIX

GeneReviews identifies defective degradation of these matrix proteins as central to CTSK-related pycnodysostosis. (NCBI)

CTSK

The relevant gene is:

CTSK

located on chromosome:

1q21.3

CTSK encodes:

CATHEPSIN K

Pycnodysostosis results from:

LOSS-OF-FUNCTION

pathogenic variants.

Therefore:

CTSK LOSS OF FUNCTION CATHEPSIN K DEFICIENCY COLLAGEN/MATRIX DEGRADATION IMPAIRED OSTEOCLAST RESORPTION IMPAIRED ABNORMAL SKELETAL REMODELING

(NCBI)

Osteoclasts Are Present

This is a crucial distinction.

Osteoclasts are present in pycnodysostosis, but their matrix-degrading function is impaired.

In pycnodysostosis:

OSTEOCLAST NUMBERS CAN BE NORMAL

and osteoclasts can have:

  • ruffled borders;
  • clear zones.

The major defect lies in effective degradation of the organic matrix after mineral dissolution. (NCBI)

This makes the disease an excellent mechanistic teaching model.

Pycnodysostosis Versus Osteopetrosis Mechanism

Osteopetrosis

Broad group of disorders in which osteoclast-mediated bone resorption is impaired through mechanisms such as:

  • osteoclast dysfunction;
  • acidification failure;
  • chloride/proton handling abnormalities;
  • differentiation defects.

Pycnodysostosis

A much more specific defect:

CATHEPSIN K–DEPENDENT MATRIX DEGRADATION FAILURE

Therefore:

OSTEOPETROSIS = BROADER RESORPTION FAILURE

while:

PYCNODYSOSTOSIS = CTSK/CATHEPSIN K MATRIX-DEGRADATION FAILURE
Pycnodysostosis pathway from biallelic CTSK variants and cathepsin K deficiency to impaired bone matrix degradation, osteosclerosis, fragility and acroosteolysis.
Pycnodysostosis pathway from biallelic CTSK variants and cathepsin K deficiency to impaired bone matrix degradation, osteosclerosis, fragility and acroosteolysis.

Distinctive Skeletal Phenotype

Short Stature

Short stature is a major feature.

The typical pattern is:

SHORT-LIMBED SHORT STATURE

GeneReviews describes short-limbed short stature as present in essentially all affected individuals, although severity varies. (NCBI)

Growth impairment varies among affected children.

Growth Hormone

Some affected individuals have:

  • growth-hormone deficiency;
  • low IGF-1.

Therefore growth assessment should include consideration of endocrine evaluation where clinically appropriate.

GeneReviews recommends evaluation for:

GH AND IGF-1 DEFICIENCY

early in the assessment of an affected individual. (NCBI)

Important:

SHORT STATURE IN PYCNODYSOSTOSIS IS NOT AUTOMATICALLY GH DEFICIENCY

The skeletal dysplasia itself contributes substantially.

Acroosteolysis

One of the most characteristic findings is:

ACROOSTEOLYSIS

This means resorption/loss of bone involving the:

DISTAL / TERMINAL PHALANGES

Hand radiographs may show partial or substantial loss of terminal phalangeal bone.

This can produce:

  • shortened fingertips;
  • brachydactyly;
  • abnormal distal digits.

The Paradox Of Acroosteolysis

The disease causes:

GENERALIZED OSTEOSCLEROSIS

yet also:

LOCALIZED ACROOSTEOLYSIS

This initially seems contradictory.

The precise biological explanation for this regional phenotype is more complex than simply “too much osteoclast activity.”

Instead teach:

PYCNODYSOSTOSIS CHARACTERISTICALLY COMBINES GENERALIZED DENSE BONE WITH DISTAL PHALANGEAL BONE LOSS

This combination is diagnostically powerful.

Brachydactyly

Affected individuals commonly have:

BRACHYDACTYLY

The fingers may appear:

  • short;
  • broad;
  • abnormal at the distal phalanges.

Nail abnormalities can also occur.

Examples include:

  • dysplastic nails;
  • flattened nails;
  • grooved nails. (NCBI)

Skull Findings

Important cranial manifestations include:

  • delayed fusion of cranial sutures;
  • persistently open anterior fontanelle;
  • frontal bossing;
  • craniofacial disproportion.

Therefore an older child with:

PERSISTENTLY OPEN FONTANELLE + OSTEOSCLEROSIS

should trigger consideration of pycnodysostosis.

Facial Phenotype

Characteristic features can include:

FRONTAL BOSSING CONVEX NASAL RIDGE MIDFACE RETRUSION SMALL JAW

The facial phenotype can become more apparent with age. (NCBI)

Avoid portraying facial appearance as sufficient for diagnosis by itself.

The Mandible

A particularly useful radiographic clue is:

LOSS OF THE NORMAL MANDIBULAR ANGLE

producing an:

OBTUSE MANDIBULAR ANGLE

This is a classic feature.

Therefore the diagnostic combination:

OSTEOSCLEROSIS + ACROOSTEOLYSIS + OBTUSE MANDIBULAR ANGLE

is highly characteristic.

GeneReviews notes that the combination of acroosteolysis, osteosclerosis and loss of the normal jaw angle is almost pathognomonic, although formal diagnostic criteria have not been established. (NCBI)

Dental Abnormalities

Dental manifestations are important.

They can include:

  • delayed eruption of deciduous teeth;
  • delayed eruption of permanent teeth;
  • retained deciduous teeth;
  • double rows of teeth;
  • hypodontia;
  • malocclusion;
  • dental crowding;
  • increased dental-management complexity.

The maxilla and mandible may be hypoplastic.

Dental care should therefore be part of multidisciplinary management. (NCBI)

Why Dental Care Matters

Dental problems are not merely cosmetic.

They can affect:

  • chewing;
  • oral hygiene;
  • dental alignment;
  • infection risk;
  • orthodontic planning;
  • surgical planning.

Therefore:

PYCNODYSOSTOSIS REQUIRES LONG-TERM DENTAL / ORTHODONTIC ATTENTION

Clavicles

Clavicular abnormalities can include:

CLAVICULAR DYSPLASIA

and occasionally:

CONGENITAL PSEUDARTHROSIS

This contributes to overlap with:

CLEIDOCRANIAL DYSPLASIA

but the underlying disorders are different. (NCBI)

Fractures and Orthopedic Features

Fractures

Despite generalized osteosclerosis:

FRACTURES ARE COMMON

Fractures can occur after relatively modest trauma.

Long bones are particularly relevant.

The important teaching point is:

HIGH RADIOGRAPHIC DENSITY DOES NOT PROTECT AGAINST FRACTURE

Fracture Healing

Fracture management can be challenging.

Reported orthopedic complications include:

NON-UNION

and operative treatment can be technically difficult because abnormal dense bone is not equivalent to normal healthy cortical bone.

GeneReviews notes that a substantial proportion of reported patients have required orthopedic intervention and that non-union after surgery has been described. (NCBI)

Scoliosis

Scoliosis can occur.

Clinical examination should therefore include assessment of:

  • spinal alignment;
  • asymmetry;
  • functional effects.

Management is individualized by orthopedics.

Airway, Sleep and Craniofacial Complications

Airway And Sleep Apnea

Craniofacial anatomy can predispose to:

UPPER-AIRWAY OBSTRUCTION

Potential manifestations include:

  • narrow upper airway;
  • stridor;
  • laryngomalacia;
  • obstructive sleep apnea.

GeneReviews recommends early sleep assessment and specialist management when needed. (NCBI)

Obstructive Sleep Apnea

OSA is an important complication because it may affect:

  • sleep quality;
  • daytime function;
  • cardiovascular health;
  • perioperative risk.

GeneReviews recommends polysomnography as part of initial evaluation and includes ongoing sleep surveillance. (NCBI)

Anesthesia

Craniofacial abnormalities may make:

AIRWAY MANAGEMENT / INTUBATION DIFFICULT

Therefore before planned general anesthesia:

THE ANESTHESIA TEAM SHOULD BE AWARE OF THE DIAGNOSIS AND POTENTIAL DIFFICULT AIRWAY

GeneReviews explicitly recommends consideration of difficult intubation before general anesthesia. (NCBI)

Neurological/Craniofacial Complications

Selected patients may have additional craniofacial abnormalities such as:

  • craniosynostosis;
  • cleft/high-arched palate;
  • maxillary or mandibular hypoplasia.

If neurological symptoms raise concern for structural abnormalities such as Chiari malformation, targeted neurological evaluation/imaging may be appropriate. (NCBI)

Repeated brain MRI is not required for every patient.

Hearing And Vision

Baseline assessment may include:

  • audiology;
  • ophthalmological evaluation.

GeneReviews recommends both as part of the initial evaluation. (NCBI)

Laboratory Findings

Laboratory Findings

This is another high-yield diagnostic point.

Despite striking radiographic bone abnormalities, routine mineral biochemistry can be:

NORMAL

GeneReviews lists typical laboratory findings as normal:

  • serum calcium;
  • phosphate;
  • vitamin D;
  • alkaline phosphatase. (NCBI)

Therefore:

NORMAL Ca + PO₄ + ALP DOES NOT EXCLUDE A MAJOR GENETIC BONE DISORDER

This contrasts strongly with hypophosphatasia.

ALP Comparison With Hypophosphatasia

Pycnodysostosis

ALP TYPICALLY NORMAL

Hypophosphatasia

PERSISTENTLY LOW ALP IS A CENTRAL DIAGNOSTIC CLUE

Therefore:

DENSE/FRAGILE BONE + NORMAL ALP + ACROOSTEOLYSIS → THINK CTSK/PYCNODYSOSTOSIS

whereas:

FRAGILITY/MINERALIZATION DISORDER + PERSISTENTLY LOW ALP → THINK HPP

Radiology

Radiology

Radiology is central to diagnosis.

Characteristic findings include:

GENERALIZED OSTEOSCLEROSIS ACROOSTEOLYSIS OF TERMINAL PHALANGES DELAYED CRANIAL-SUTURE FUSION OBTUSE MANDIBULAR ANGLE

Other findings can include:

  • clavicular dysplasia;
  • congenital clavicular pseudarthrosis;
  • fractures;
  • non-pneumatized mastoids. (NCBI)

Hand Radiograph

The hand radiograph is particularly educational.

Look for:

ACROOSTEOLYSIS

at the terminal phalanges.

Also note:

  • generalized increased bone density;
  • short distal digits.

This image can provide one of the strongest clues to the diagnosis.

Skull Radiograph / Imaging

Potential findings include:

  • delayed closure of sutures;
  • open fontanelle;
  • cranial sclerosis;
  • abnormal jaw morphology;
  • non-pneumatized mastoids.

CT is not required simply to prove the diagnosis in every patient.

GeneReviews suggests considering skull CT when there is clinical concern regarding craniosynostosis. (NCBI)

Skeletal Survey

Once the diagnosis is established, GeneReviews recommends a complete radiographic skeletal survey including lateral spine radiographs as part of the initial assessment of disease extent. (NCBI)

Radiographic features of pycnodysostosis showing terminal phalangeal acroosteolysis, generalized osteosclerosis, delayed cranial suture closure and obtuse mandibular angle.
Radiographic features of pycnodysostosis showing terminal phalangeal acroosteolysis, generalized osteosclerosis, delayed cranial suture closure and obtuse mandibular angle.

Diagnosis and Genetic Testing

Diagnosis

There are:

NO FORMALLY ESTABLISHED DIAGNOSTIC CRITERIA

for pycnodysostosis.

Diagnosis can be established using:

CHARACTERISTIC CLINICAL FEATURES CHARACTERISTIC RADIOGRAPHIC FEATURES

and/or:

BIALLELIC PATHOGENIC CTSK VARIANTS

(NCBI)

High-Yield Diagnostic Pattern

SHORT STATURE OSTEOSCLEROSIS FRACTURES ACROOSTEOLYSIS DELAYED CRANIAL-SUTURE CLOSURE OBTUSE MANDIBULAR ANGLE THINK PYCNODYSOSTOSIS

Genetic Testing

When the phenotype is strongly suggestive, molecular testing can include:

CTSK SEQUENCE ANALYSIS

or a suitable:

MULTIGENE PANEL

When the phenotype overlaps broadly with other skeletal dysplasias, exome/genome approaches may be considered.

GeneReviews reports that sequence analysis identifies the great majority of known CTSK pathogenic variants, while rare structural variants may require additional methods. (NCBI)

Clinical assessment is not 100% sensitive.

Variant Of Uncertain Significance

A:

VUS

does not by itself establish the diagnosis.

Similarly, one pathogenic CTSK variant plus a VUS does not automatically prove an autosomal-recessive molecular diagnosis.

Interpret molecular findings in:

CLINICAL + RADIOGRAPHIC + GENETIC CONTEXT

(NCBI)

Inheritance

Pycnodysostosis is:

AUTOSOMAL RECESSIVE

For a classic family in which both parents are confirmed carriers:

each pregnancy has:

25% affected 50% carrier 25% unaffected non-carrier

risk.

This is per conception, not something that changes according to previous children's outcomes. (NCBI)

Consanguinity

Because the disease is autosomal recessive, consanguinity may increase the likelihood that both parents carry the same rare pathogenic variant.

However:

ABSENCE OF CONSANGUINITY DOES NOT EXCLUDE PYCNODYSOSTOSIS

and:

ABSENCE OF FAMILY HISTORY DOES NOT EXCLUDE IT

(NCBI)

Genetic Counseling

Once familial CTSK pathogenic variants are identified:

  • carrier testing for at-risk relatives may be possible;
  • prenatal testing may be possible;
  • preimplantation genetic testing may be possible.

These require appropriate genetic counseling. (NCBI)

Differential Diagnosis

Differential Diagnosis

The major differentials should include:

  1. osteopetrosis;
  2. cleidocranial dysplasia;
  3. hypophosphatasia;
  4. osteogenesis imperfecta;
  5. other sclerosing bone dysplasias.

The most important comparison is:

PYCNODYSOSTOSIS VS OSTEOPETROSIS

Pycnodysostosis Versus Osteopetrosis

FeaturePycnodysostosisOsteopetrosis
Core defectCathepsin K matrix degradationVarious osteoclast-resorption defects
Major geneCTSKTCIRG1, CLCN7 and others
InheritanceAutosomal recessiveDepends on subtype
OsteosclerosisYesYes
Bone fragilityYesYes
AcroosteolysisCharacteristicNot typical
Short statureCharacteristicVariable
Open cranial suturesCharacteristicNot defining
Obtuse mandibular angleCharacteristicNot defining
Marrow failureRare/not typicalMajor feature of severe forms
Cranial-nerve compressionLess definingImportant in severe disease
HSCTNo established roleCan be definitive in selected severe forms

This final row is extremely important.

GeneReviews specifically emphasizes differentiating pycnodysostosis from severe osteopetrosis because early HSCT can benefit selected osteopetrosis forms but:

HSCT WOULD NOT BENEFIT PYCNODYSOSTOSIS

(NCBI)

Why HSCT Does Not Solve Pycnodysostosis

Shared osteoclast involvement does not mean both disorders respond to bone-marrow transplantation.

The biology differs.

In selected severe osteopetrosis, replacing hematopoietic osteoclast precursors can restore functional osteoclast activity.

Pycnodysostosis is a distinct CTSK-related disorder and:

HSCT IS NOT ESTABLISHED AS A TREATMENT

This distinction can prevent a major conceptual error.

Pycnodysostosis Versus Cleidocranial Dysplasia

Use:

FeaturePycnodysostosisCleidocranial dysplasia
GeneCTSKRUNX2
InheritanceARUsually AD
Short statureYesOften
Open fontanelle/suturesYesYes
Clavicular abnormalitiesYesClassic
Dental abnormalitiesYesClassic
OsteosclerosisCharacteristicNot defining
AcroosteolysisCharacteristicNot typical
Fragility fracturesImportantNot defining
Obtuse mandibular angleCharacteristicDifferent craniofacial pattern

Memory:

OPEN SUTURES + DENTAL/CLAVICLE FEATURES CAN LOOK LIKE CCD

but:

OSTEOSCLEROSIS + ACROOSTEOLYSIS POINT TOWARD PYCNODYSOSTOSIS

Pycnodysostosis Versus Hypophosphatasia

FeaturePycnodysostosisHypophosphatasia
GeneCTSKALPL
Main mechanismImpaired osteoclast matrix degradationDefective mineralization
ALPUsually normalPersistently low
Bone densityIncreasedVariable
AcroosteolysisCharacteristicNot defining
Premature tooth lossNot classic mechanismImportant clue
FracturesYesYes
Targeted enzyme replacementNo established CTSK replacementAsfotase alfa for appropriate HPP

Pycnodysostosis Versus Osteogenesis Imperfecta

FeaturePycnodysostosisOI
Main mechanismOsteoclast matrix-degradation defectCollagen matrix disorder
Major gene(s)CTSKOften COL1A1/COL1A2
Bone densityIncreasedOften reduced/variable
FracturesYesYes
AcroosteolysisCharacteristicNo
Open fontanelleCan persistMay occur in severe phenotypes but not defining
Blue scleraeMay occasionally be noted but not definingClassic in some OI types
Dentinogenesis imperfectaNot definingImportant in some OI

Treatment Principles

Treatment Philosophy

There is no established treatment that:

CORRECTS THE CTSK MUTATION

or:

NORMALIZES SKELETAL REMODELING THROUGHOUT THE BODY

Management is therefore:

MULTIDISCIPLINARY + COMPLICATION-DIRECTED

Key domains:

  • growth;
  • fractures;
  • scoliosis;
  • craniofacial disease;
  • airway/sleep;
  • dental disease;
  • vision/hearing;
  • perioperative planning;
  • genetic counseling.

GeneReviews states that there are no published standard treatment/surveillance guidelines specific to pycnodysostosis and recommends multidisciplinary management. (NCBI)

Fracture Management

Fractures require:

SPECIALIST ORTHOPEDIC MANAGEMENT

Treatment may involve:

  • immobilization;
  • osteosynthesis;
  • other individualized orthopedic strategies.

But abnormal dense bone can make intervention challenging.

Potential complications include:

NON-UNION

Bisphosphonates

DO NOT TREAT PYCNODYSOSTOSIS LIKE OSTEOPOROSIS

Because the disease already involves:

IMPAIRED OSTEOCLAST FUNCTION

further antiresorptive suppression is biologically inappropriate as routine therapy.

GeneReviews specifically states:

BISPHOSPHONATE THERAPY IS CONTRAINDICATED

because of the underlying osteoclast dysfunction. (NCBI)

Growth Management

Monitor:

  • height;
  • growth velocity;
  • nutritional status.

Consider endocrinology evaluation, particularly where:

  • growth failure is marked;
  • GH/IGF-1 deficiency is suspected.

Growth-hormone therapy may be considered in appropriate patients under specialist care. (NCBI)

Dental Management

Dental/orthodontic follow-up is important because of:

  • delayed eruption;
  • retained deciduous teeth;
  • malocclusion;
  • hypodontia;
  • jaw abnormalities.

Management should involve clinicians familiar with the craniofacial/skeletal context where possible.

Craniofacial Management

Selected patients may require specialist assessment for:

  • craniosynostosis;
  • maxillary hypoplasia;
  • mandibular hypoplasia;
  • cleft/high-arched palate;
  • functional craniofacial problems.

Surgical decisions are individualized.

Sleep/Airway Management

Patients with suspected OSA or upper-airway obstruction require:

RESPIRATORY / SLEEP SPECIALIST ASSESSMENT

GeneReviews recommends polysomnography early in evaluation. (NCBI)

Treatment depends on the individual anatomy and severity.

Initial Evaluation

After diagnosis, assessment should cover:

Growth

  • height/growth;
  • GH/IGF-1 where appropriate.

Skeleton

  • disease extent;
  • fractures;
  • scoliosis;
  • skeletal survey;
  • orthopedic assessment.

Craniofacial/ENT

  • palate;
  • nasal airway;
  • hearing.

Respiratory

  • sleep-disordered breathing.

Dental

  • baseline dental evaluation.

Neurological

  • targeted assessment/imaging if symptoms suggest structural neurological complications.

Eyes

  • baseline ophthalmology.

Genetics

  • pedigree and counseling.

These domains align with GeneReviews' recommended initial evaluation. (NCBI)

Surveillance

GeneReviews suggests ongoing assessment particularly for:

  • scoliosis;
  • asymmetry;
  • fracture frequency;
  • growth/weight/nutrition;
  • dental issues;
  • vision;
  • sleep apnea. (NCBI)

Pregnancy

Women with pycnodysostosis may have skeletal/pelvic considerations relevant to pregnancy and delivery.

Management should involve individualized obstetric and anesthetic assessment.

GeneReviews notes that cesarean delivery may be considered in patients with a small pelvis but emphasizes individual assessment. (NCBI)

Cesarean delivery is not required for every affected woman.

Master Pathophysiology Algorithm

BIALLELIC CTSK VARIANTS CATHEPSIN K ↓ ORGANIC BONE-MATRIX DEGRADATION ↓ OSTEOCLAST RESORPTION IMPAIRED BONE REMODELING ↓

Two important consequences:

General skeleton

OSTEOSCLEROSIS ABNORMAL BONE QUALITY FRACTURES

Distal phalanges

ACROOSTEOLYSIS

Also:

CRANIOFACIAL + DENTAL + GROWTH PHENOTYPE

Bottom memory:

DENSE BONE ≠ STRONG BONE

Master Diagnostic Algorithm

SHORT STATURE + FRACTURES + DENSE BONES LOOK AT THE HANDS

Acroosteolysis?

If yes:

LOOK FOR PYCNODYSOSTOSIS CLUES
  • open fontanelle / delayed sutures;
  • small jaw;
  • obtuse mandibular angle;
  • convex nasal ridge;
  • dental abnormalities;
  • clavicular dysplasia.
ROUTINE BONE BIOCHEMISTRY

Often normal.

RADIOGRAPHIC PATTERN

Osteosclerosis + acroosteolysis + craniofacial findings.

CTSK MOLECULAR TESTING CONFIRM / SUPPORT DIAGNOSIS ASSESS FRACTURE + GROWTH + DENTAL + AIRWAY + CRANIOFACIAL NEEDS

Bottom:

OSTEOSCLEROSIS + ACROOSTEOLYSIS = A MAJOR PYCNODYSOSTOSIS CLUE

Dense-Bone Diagnostic Algorithm

GENERALIZED OSTEOSCLEROSIS

Bone-marrow failure / cranial-nerve compression prominent?

Think:

OSTEOPETROSIS

Acroosteolysis + short stature + open sutures + obtuse jaw?

Think:

PYCNODYSOSTOSIS

Renal tubular acidosis / cerebral calcification?

Consider:

CARBONIC ANHYDRASE II–RELATED OSTEOPETROSIS

Other distinctive sclerosing phenotype?

Evaluate for other skeletal dysplasia.

Bottom:

NOT ALL DENSE-BONE DISORDERS ARE THE SAME OSTEOCLAST DISEASE

Worked Clinical Cases

Case 1 — Dense but fragile

A short child has recurrent fractures.

Radiographs show generalized increased bone density.

Wrong conclusion

“Dense bones mean fractures should not occur.”

Correct principle

DENSE ≠ STRONG

Consider an osteoclast/remodeling disorder.

Case 2 — Acroosteolysis

Hand radiograph demonstrates osteosclerosis with loss of the terminal phalanges.

Key clue

ACROOSTEOLYSIS

When combined with short stature and dense bones:

THINK PYCNODYSOSTOSIS

Case 3 — Open fontanelle

An older child has persistent opening of the anterior fontanelle, frontal bossing, short stature and dense bones.

Diagnostic direction

PYCNODYSOSTOSIS

especially if acroosteolysis and jaw abnormalities are present.

Case 4 — Jaw radiograph

A child has a small jaw and loss of the normal gonial angle.

Radiographic clue

OBTUSE MANDIBULAR ANGLE

This is characteristic of pycnodysostosis.

Case 5 — Normal biochemical tests

Child has multiple skeletal abnormalities.

Calcium, phosphate and ALP are normal.

Wrong conclusion

“Normal bone profile means there is no bone disease.”

Correct principle

PYCNODYSOSTOSIS CAN HAVE NORMAL ROUTINE MINERAL BIOCHEMISTRY

Case 6 — Pycnodysostosis versus osteopetrosis

A patient has osteosclerosis and fractures but no marrow failure.

Hand films show striking acroosteolysis and the patient has short stature and an open fontanelle.

Most likely

PYCNODYSOSTOSIS

rather than classic severe osteopetrosis.

Case 7 — HSCT question

Family asks whether bone-marrow transplantation used for severe osteopetrosis should be performed.

Answer

NO ESTABLISHED ROLE IN PYCNODYSOSTOSIS

The two disorders must not be therapeutically equated. (NCBI)

Case 8 — Cleidocranial dysplasia differential

Child has delayed cranial-suture closure, dental abnormalities and clavicular dysplasia.

But radiographs also show:

  • generalized osteosclerosis;
  • terminal-phalanx acroosteolysis.

Diagnosis favored

PYCNODYSOSTOSIS

The last two findings strongly separate it from typical cleidocranial dysplasia.

Case 9 — Recurrent fracture

Adult with known pycnodysostosis sustains another long-bone fracture.

Principle

Fracture treatment requires specialist orthopedic care because:

ABNORMAL DENSE BONE CAN BE TECHNICALLY DIFFICULT TO TREAT

and non-union has been reported.

Case 10 — Sleep apnea

Child with pycnodysostosis snores loudly and has witnessed apneas.

Correct response

ASSESS FOR OBSTRUCTIVE SLEEP APNEA

This presentation warrants assessment rather than dismissal as ordinary childhood snoring.

Case 11 — Surgery planned

Patient with craniofacial abnormalities is scheduled for general anesthesia.

Important communication

POTENTIAL DIFFICULT AIRWAY

must be recognized during preoperative planning. (NCBI)

Case 12 — Two carrier parents

Both parents carry the familial pathogenic CTSK variant.

They ask about the next pregnancy.

Per-conception probabilities

25% affected 50% carrier 25% unaffected non-carrier

(NCBI)

Common Mistakes

Mistake 1

Dense bones mean strong bones. Wrong.

Mistake 2

Pycnodysostosis is simply another name for osteopetrosis. Wrong.

Mistake 3

Pycnodysostosis occurs because osteoclasts are absent. Wrong.

Mistake 4

CTSK encodes a collagen protein. Wrong.

Mistake 5

Cathepsin K mainly creates bone mineral. Wrong.

Mistake 6

Acroosteolysis contradicts the diagnosis because the disease causes sclerosis. Wrong.

Mistake 7

Acroosteolysis is typical of every osteopetrosis subtype. Wrong.

Mistake 8

Short stature proves GH deficiency. Wrong.

Mistake 9

An open fontanelle alone diagnoses pycnodysostosis. Wrong.

Mistake 10

Clavicular abnormalities mean the patient must have cleidocranial dysplasia. Wrong.

Mistake 11

Normal calcium and phosphate exclude skeletal dysplasia. Wrong.

Mistake 12

Normal ALP excludes pycnodysostosis. Wrong.

Mistake 13

Persistently low ALP is characteristic of pycnodysostosis. Wrong — think HPP.

Mistake 14

All dense-bone disorders cause marrow failure. Wrong.

Mistake 15

HSCT used for severe osteopetrosis also treats pycnodysostosis. Wrong.

Mistake 16

Bisphosphonates should be used because the patient fractures. Wrong.

Mistake 17

Dental abnormalities are only cosmetic. Wrong.

Mistake 18

Airway anatomy is irrelevant to anesthesia. Wrong.

Mistake 19

Absence of consanguinity excludes an autosomal-recessive disorder. Wrong.

Mistake 20

One CTSK VUS automatically establishes the diagnosis. Wrong.

Pycnodysostosis in One Minute

PYCNODYSOSTOSIS IN ONE MINUTE CTSK LOSS OF FUNCTION CATHEPSIN K ↓ COLLAGEN / ORGANIC MATRIX DEGRADATION ↓ OSTEOCLAST RESORPTION ↓ OSTEOSCLEROSIS

but:

BONE REMAINS FRAGILE

Classic clues:

SHORT STATURE ACROOSTEOLYSIS OPEN CRANIAL SUTURES SMALL JAW OBTUSE MANDIBULAR ANGLE DENTAL ABNORMALITIES

Labs:

Ca / PO₄ / ALP OFTEN NORMAL

Inheritance:

AUTOSOMAL RECESSIVE

Treatment:

COMPLICATION-DIRECTED MULTIDISCIPLINARY CARE

Not:

HSCT

Not:

ROUTINE BISPHOSPHONATES

Final:

DENSE BONE + ACROOSTEOLYSIS = THINK PYCNODYSOSTOSIS

Frequently Asked Questions

What is pycnodysostosis?

Pycnodysostosis is a rare autosomal-recessive skeletal dysplasia characterized by osteosclerosis, bone fragility, short stature, acroosteolysis and characteristic craniofacial and dental abnormalities.

What gene causes pycnodysostosis?

It is caused by biallelic pathogenic variants in CTSK, which encodes cathepsin K.

What does cathepsin K do?

Cathepsin K is an osteoclast lysosomal protease that helps degrade organic bone-matrix proteins, especially collagen, during bone resorption.

Why are bones dense in pycnodysostosis?

Defective cathepsin K reduces normal osteoclast degradation of bone matrix, impairing resorption and remodeling and producing generalized osteosclerosis.

Why do fractures occur if the bones are dense?

Radiographic density does not guarantee normal bone quality. Abnormal remodeling produces structurally fragile bone despite osteosclerosis.

What is acroosteolysis?

Acroosteolysis is loss/resorption of bone from the distal phalanges. It is one of the characteristic radiographic features of pycnodysostosis.

What are the classic craniofacial features?

They include frontal bossing, a convex nasal ridge, midface retrusion, a small jaw, delayed cranial-suture closure and an obtuse mandibular angle.

What dental abnormalities occur?

Delayed tooth eruption, retained deciduous teeth, double rows of teeth, hypodontia and other dental/orthodontic abnormalities may occur.

Are calcium and phosphate abnormal?

Routine serum calcium, phosphate, vitamin D and alkaline phosphatase are typically normal.

How is pycnodysostosis diagnosed?

Diagnosis is based on characteristic clinical/radiographic findings and/or identification of biallelic pathogenic CTSK variants. Formal diagnostic criteria have not been established.

How is it different from osteopetrosis?

Both can cause osteosclerosis and fractures, but acroosteolysis, short stature, delayed cranial-suture closure and the characteristic jaw findings strongly favor pycnodysostosis. Severe marrow failure is much more characteristic of certain osteopetrosis forms.

Can bone-marrow transplantation treat pycnodysostosis?

It is not an established treatment and would not be expected to provide the benefit seen in selected hematopoietic forms of severe osteopetrosis.

Are bisphosphonates used?

GeneReviews lists bisphosphonate therapy as contraindicated because pycnodysostosis already involves underlying osteoclast dysfunction.

Can pycnodysostosis cause sleep apnea?

Yes. Craniofacial and upper-airway abnormalities can predispose to obstructive sleep apnea.

Is pycnodysostosis inherited?

Yes. It is autosomal recessive. When both parents are confirmed carriers, each pregnancy has a 25% chance of an affected child.

Key Take-Home Messages

Pycnodysostosis is caused by:

BIALLELIC CTSK PATHOGENIC VARIANTS

leading to:

CATHEPSIN K DEFICIENCY

Cathepsin K is required for effective osteoclast degradation of:

ORGANIC BONE MATRIX

Therefore:

MATRIX DEGRADATION ↓ BONE RESORPTION / REMODELING ↓ OSTEOSCLEROSIS

But:

OSTEOSCLEROSIS DOES NOT MEAN NORMAL BONE QUALITY

Therefore patients can develop:

RECURRENT FRACTURES

The most characteristic diagnostic combination is:

SHORT STATURE DENSE BONES ACROOSTEOLYSIS DELAYED CRANIAL-SUTURE CLOSURE OBTUSE MANDIBULAR ANGLE

Routine:

CALCIUM + PHOSPHATE + ALP MAY BE NORMAL

Therefore normal bone biochemistry does not exclude the disorder.

Distinguish it carefully from osteopetrosis because:

SELECTED SEVERE OSTEOPETROSIS → HSCT MAY BE DEFINITIVE

but:

PYCNODYSOSTOSIS → HSCT IS NOT AN ESTABLISHED TREATMENT

And do not treat the radiographic sclerosis as osteoporosis:

BISPHOSPHONATES ARE NOT ROUTINE THERAPY AND GENEReviews LISTS THEM AS CONTRAINDICATED

The final memory statement:

PYCNODYSOSTOSIS = CTSK DEFICIENCY → DENSE BUT FRAGILE BONE + ACROOSTEOLYSIS + SHORT STATURE + CRANIOFACIAL/DENTAL CLUES.